New Zealand’s Synlait Agrees $177M Asset Sales to Reduce Debt
PositiveFinancial Markets

Synlait Milk has made a strategic move by agreeing to sell several of its assets to Abbott Laboratories for NZ$307 million, which is about $177 million. This sale is crucial for Synlait as it aims to reduce its debt and improve its financial standing after facing losses and underperformance. Such a decision not only helps stabilize the company but also reflects a proactive approach to managing its resources effectively.
— Curated by the World Pulse Now AI Editorial System